DELTEC ASSET MANAGEMENT LLC - VYNE THERAPEUTICS INC ownership

VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 2 filers reported holding VYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DELTEC ASSET MANAGEMENT LLC ownership history of VYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$4,500
-35.7%
30,0000.0%0.00%
-50.0%
Q3 2022$7,000
-41.7%
30,0000.0%0.00%
-33.3%
Q2 2022$12,000
-40.0%
30,0000.0%0.00%0.0%
Q1 2022$20,000
-35.5%
30,0000.0%0.00%
-40.0%
Q4 2021$31,000
-26.2%
30,0000.0%0.01%
-16.7%
Q3 2021$42,000
-96.9%
30,000
-92.2%
0.01%
-96.8%
Q2 2021$1,357,000
-55.1%
386,491
-12.5%
0.19%
-58.5%
Q1 2021$3,022,000441,4910.45%
Other shareholders
VYNE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,551,000$2,602,0002.01%
Perceptive Advisors 4,356,044$4,444,0000.03%
GSA CAPITAL PARTNERS LLP 217,747$222,0000.03%
Virtu Financial LLC 175,278$179,0000.02%
XTX Topco Ltd 17,053$17,0000.01%
SkyOak Wealth, LLC 27,200$28,0000.01%
DELTEC ASSET MANAGEMENT LLC 30,000$31,0000.01%
Tekla Capital Management LLC 135,395$138,0000.00%
STALEY CAPITAL ADVISERS INC 62,500$64,0000.00%
TWO SIGMA SECURITIES, LLC 47,475$48,0000.00%
View complete list of VYNE THERAPEUTICS INC shareholders